Holen Sie sich die Stockscreener-App
1.03
12.71%
-0.15
Handel nachbörslich:
1.04
0.01
+0.97%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TLRY?
Forum
Prognose
Aktiensplit
Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten
Tilray Brands (NASDAQ:TLRY) Stock Price Up 17.3%Time to Buy? - MarketBeat
Cannabis Stocks Worth WatchingAugust 14th - MarketBeat
Tilray Brands (NASDAQ:TLRY) Stock Price Down 4.4%What's Next? - MarketBeat
Dear Tilray Stock Fans, Mark Your Calendars for September 21 - Yahoo Finance
Beverages, Alcohol, and Tobacco Stocks Q2 Teardown: Tilray (NASDAQ:TLRY) Vs The Rest - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Stock Traders Purchase Large Volume of Call Options on Tilray Brands (NASDAQ:TLRY) - MarketBeat
Tilray Brands shares fall 2.54% after-hours as the company seeks Nasdaq extension to meet minimum share price rule. - AInvest
Earnings live: Applied Materials stock falls on Q4 guidance, Quantum Computing sinks - Yahoo Finance
SunOpta, Tilray, Olaplex, Energizer, and Hain Celestial Shares Plummet, What You Need To Know - TradingView
Dear Tilray Stock Fans, Mark Your Calendars For September 21 - Barchart.com
Tilray Eyes Reverse Stock Split As Nasdaq Listing Compliance Pressure Mounts - AOL.com
Tilray Brands Seeks Nasdaq Compliance Extension and Considers Reverse Stock Split - AInvest
Tilray Partners with Molteni in Italy to Broaden Access to Medical Cannabis Extracts - mg Magazine
If You'd Invested $1,000 in Tilray (TLRY) Stock 5 Years Ago, Here's How Much You'd Have Today - MSN
What's Going On With Tilray Brands Stock Thursday?Tilray Brands (NASDAQ:TLRY) - Benzinga
Tilray Brands (NASDAQ:TLRY) Shares Gap DownTime to Sell? - MarketBeat
Tilray Brands: Improved Fundamentals, Strengthened Balance Sheet, and Revitalized Narrative - AInvest
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative - Seeking Alpha
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance - Cannabis Business Times
Tilray Shares Drop After Seeking Extension to Meet Nasdaq Listing Requirements - MSN
Tilray Brands Stock Plummet: Opportunity Ahead? - timothysykes.com
Tilray stock falls after seeking extension to meet Nasdaq listing rules - Investing.com
Tilray's Strategic Fight to Maintain Nasdaq Listing and Unlock Long-Term Value - AInvest
Tilray Brands Seeks Nasdaq Extension to Meet Minimum Share Price Rule - MarketScreener
Tilray Requests Extension to Meet Nasdaq Listing Requirements - MarketScreener
Tilray Brands reconfirms strategy to regain Nasdaq compliance - MarketScreener
Tilray seeks Nasdaq extension amid share price compliance issues By Investing.com - Investing.com Canada
Tilray seeks Nasdaq extension amid share price compliance issues - Investing.com
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements - GlobeNewswire
Tilray Plans to Keep Nasdaq Listing as Cannabis Stocks Rise on Rescheduling News - Stock Titan
Tilray Brands shares rise 2.40% premarket after forming strategic partnerships in Italy to broaden access to medical cannabis extracts. - AInvest
Tilray Brands (NASDAQ:TLRY) Shares Gap UpHere's What Happened - MarketBeat
Tilray Requests Extension To Regain Compliance With Nasdaq, Retail Investors Call It A ‘Smart Move - Stocktwits
Earnings live: CoreWeave stock tumbles 20%, Cava falls, Cisco posts slight beat on AI demand - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Trading 14.4% HigherWhat's Next? - MarketBeat
Breakout Traders Target Tilray Brands Inc. on Recovery SetupJuly 2025 Volume & High Return Trade Guides - beatles.ru
Promising Cannabis Stocks To Add to Your WatchlistAugust 13th - MarketBeat
This Cannabis Stock Popped 26% Today After Announcing Partnership With An Italian Company – Do You Own It? - Stocktwits
What's Going On With Tilray Brands Stock Today? - Benzinga
Tilray (TLRY) Stock Trades Up, Here Is Why - Yahoo Finance
Tilray Brands to continue Italian expansion with new partnership - MMJDaily
2 Stocks Down More Than 90% That Still Aren't Worth Buying - Mitrade
Tilray’s Meteoric Rise: Analyzing the Surge - StocksToTrade
Why Tilray Should Be Reduced: Assessing the Long-Term Viability and Risk-Reward Profile - AInvest
Tilray expands access to medical cannabis extracts in Italy | 2025-08-13 | Investing News - Stockhouse
Tilray Brands Downgraded to Neutral Amid Reduced Exposure - AInvest
Why This Cannabis Penny Stock Could Be Wall Street’s Next Meme Trade Breakout - Yahoo Finance
Why Tilray Should Be Reduced (NASDAQ:TLRY) - Seeking Alpha
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Cannabis Extracts - Cannabis Business Times
Tilray Brands Unit Forms Partnership to Increase Access to Medical Cannabis Extracts in Italy - MarketScreener
Strategic Alliances and Market Maturity: Tilray Medical's European Expansion as a Catalyst for Medical Cannabis Adoption - AInvest
Tilray Medical Forms Partnership in Italy to Broaden Access to Medical Cannabis Extracts - MarketScreener
Tilray Medical Forms Strategic Partnership in Italy to Broaden A - GuruFocus
Tilray Brief: Tilray's FL Group Teams Up with Molteni, a Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies - MarketScreener
Tilray Brief: Tilray Medical Forming Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts - MarketScreener
Tilray's Strategic Expansion in Italy: A Catalyst for Growth in the European Medical Cannabis Market - AInvest
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts - GlobeNewswire
TLRY Q2 Deep Dive: Regulatory Delays, Margin Focus, and International Momentum Shape Results - Yahoo Finance
Can Tilray (TLRY) Broaden Its US Reach Through New Cannabis Beverage Offerings and Evolving Regulation? - simplywall.st
Tilray Brands, Inc. shares fall 1.68% after-hours following the expansion of its hemp-derived Delta-9 THC beverage portfolio. - AInvest
2.80%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):